{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:06:34Z","timestamp":1789412794660,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"DOI":"10.1007\/s43032-026-02187-4","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:45:28Z","timestamp":1789411528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum Prostate-Specific Antigen Concentrations in Polycystic Ovary Syndrome: A Comparative Analysis of Hirsute and Non-Hirsute Phenotypes"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2452-718X","authenticated-orcid":false,"given":"Seyma Donmez","family":"Sah\u0131p","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5141-3241","authenticated-orcid":false,"given":"Mehmet Mustafa","family":"Eyol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3223-6507","authenticated-orcid":false,"given":"Ekin","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1912-7124","authenticated-orcid":false,"given":"Elif","family":"Erden Deveci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4926-4915","authenticated-orcid":false,"given":"Ibrahim Bugra","family":"Bahad\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9927-181X","authenticated-orcid":false,"given":"Batuhan","family":"Turgay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"issue":"6","key":"2187_CR1","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1016\/S0002-9378(98)70238-8","volume":"179","author":"D Guzick","year":"1998","unstructured":"Guzick D. Polycystic ovary syndrome: symptomatology, pathophysiology, and epidemiology. Am J Obstet Gynecol. 1998;179(6):S89\u201393. https:\/\/doi.org\/10.1016\/S0002-9378(98)70238-8.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2187_CR2","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1210\/jcem.83.9.5090","volume":"83","author":"E Knochenhauer","year":"1998","unstructured":"Knochenhauer E, Key T, Kahsar-Miller M, Waggoner W, Boots L, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83(9):3078\u201382. https:\/\/doi.org\/10.1210\/jcem.83.9.5090.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2187_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/09513590903247873","volume":"26","author":"D Glintborg","year":"2010","unstructured":"Glintborg D, Andersen M. An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecol Endocrinol. 2010;26(4):281\u201396. https:\/\/doi.org\/10.3109\/09513590903247873.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2187_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/09513590.2017.1370644","volume":"34","author":"G Morgante","year":"2018","unstructured":"Morgante G, Massaro M, Di Sabatino A, Cappelli V, De Leo V. Therapeutic approach for metabolic disorders and infertility in women with PCOS. Gynecol Endocrinol. 2018;34(1):4\u20139. https:\/\/doi.org\/10.1080\/09513590.2017.1370644.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"2187_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1447-0756.2007.00507.x","volume":"33","author":"B Vural","year":"2007","unstructured":"Vural B, \u00d6zkan S, Bodur H. Is prostate\u2010specific antigen a potential new marker of androgen excess in polycystic ovary syndrome? J Obstet Gynaecol Res. 2007;33(2):166\u201373. https:\/\/doi.org\/10.1111\/j.1447-0756.2007.00507.x.","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"2187_CR6","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.fertnstert.2013.12.056","volume":"101","author":"WA Salameh","year":"2014","unstructured":"Salameh WA, Redor-Goldman MM, Clarke NJ, Mathur R, Azziz R, Reitz RE. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria. Fertil Steril. 2014;101(4):1135-41. e2. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.12.056.","journal-title":"Fertil Steril"},{"issue":"3","key":"2187_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jpag.2017.11.004","volume":"31","author":"A Tokmak","year":"2018","unstructured":"Tokmak A, Bodur S, Erkilinc S, Ozel S, Engin-Ustun Y. The value of prostate-specific antigen in diagnosis of polycystic ovarian syndrome in adolescent girls. J Pediatr Adolesc Gynecol. 2018;31(3):263\u20139. https:\/\/doi.org\/10.1016\/j.jpag.2017.11.004.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"2187_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0022-5347(17)38491-4","volume":"145","author":"JE Oesterling","year":"1991","unstructured":"Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol. 1991;145(5):907\u201323. https:\/\/doi.org\/10.1016\/S0022-5347(17)38491-4.","journal-title":"J Urol"},{"issue":"7","key":"2187_CR9","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1210\/jcem.83.7.4960","volume":"83","author":"HcF Escobar-Morreale","year":"1998","unstructured":"Escobar-Morreale HcF, Serrano-Gotarredona J, Avila S, Villar-Palasi\u0301 J, Varela C, Sancho J. The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function. J Clin Endocrinol Metab. 1998;83(7):2580\u20134. https:\/\/doi.org\/10.1210\/jcem.83.7.4960.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2187_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0009-9120(94)90015-9","volume":"27","author":"H Yu","year":"1994","unstructured":"Yu H, Diamandis EP, Sutherland DJ. Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem. 1994;27(2):75\u20139. https:\/\/doi.org\/10.1016\/0009-9120(94)90015-9.","journal-title":"Clin Biochem"},{"issue":"1","key":"2187_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/jcem.85.1.6230","volume":"85","author":"C Negri","year":"2000","unstructured":"Negri C, Tosi F, Dorizzi R, Fortunato A, Spiazzi GG, Muggeo M, et al. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women. J Clin Endocrinol Metab. 2000;85(1):81\u20134. https:\/\/doi.org\/10.1210\/jcem.85.1.6230.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2187_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004.","journal-title":"Fertil Steril."},{"issue":"1","key":"2187_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/humupd\/dmp024","volume":"16","author":"BO Yildiz","year":"2010","unstructured":"Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. Visually scoring hirsutism. Hum Reprod Update. 2010;16(1):51\u201364. https:\/\/doi.org\/10.1093\/humupd\/dmp024.","journal-title":"Hum Reprod Update"},{"key":"2187_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116940","volume":"236","author":"J Wang","year":"2019","unstructured":"Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci. 2019;236:116940.","journal-title":"Life Sci"},{"key":"2187_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.envres.2016.03.015","volume":"148","author":"AG Feroe","year":"2016","unstructured":"Feroe AG, Attanasio R, Scinicariello F. Acrolein metabolites, diabetes and insulin resistance. Environ Res. 2016;148:1\u20136. https:\/\/doi.org\/10.1016\/j.envres.2016.03.015.","journal-title":"Environ Res"},{"key":"2187_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.57","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016. https:\/\/doi.org\/10.1038\/nrdp.2016.57.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"2187_CR17","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602\u201318. https:\/\/doi.org\/10.1093\/humrep\/dey256.","journal-title":"Hum Reprod"},{"issue":"3","key":"2187_CR18","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1210\/jcem.82.3.3792","volume":"82","author":"DN Melegos","year":"1997","unstructured":"Melegos DN, Yu H, Ashok M, Wang C, Stanczyk F, Diamandis EP. Prostate-specific antigen in female serum, a potential new marker of androgen excess. J Clin Endocrinol Metab. 1997;82(3):777\u201380. https:\/\/doi.org\/10.1210\/jcem.82.3.3792.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2187_CR19","first-page":"999","volume":"16","author":"F Mardanian","year":"2011","unstructured":"Mardanian F, Heidari N. Diagnostic value of prostate-specific antigen in women with polycystic ovary syndrome. J Res Med Sci. 2011;16(8):999.","journal-title":"J Res Med Sci"},{"issue":"11","key":"2187_CR20","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/09513590.2016.1200552","volume":"32","author":"E Rudnicka","year":"2016","unstructured":"Rudnicka E, Radowicki S, Suchta K. Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome\u2013a new insight. Gynecol Endocrinol. 2016;32(11):931\u20135. https:\/\/doi.org\/10.1080\/09513590.2016.1200552.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"2187_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.15406\/emij.2018.06.00192","volume":"6","author":"HM Hurjahan-Banu","year":"2018","unstructured":"Hurjahan-Banu HM, Sukanti-Shah NA, Sadiqa-Tuqan TS, Fariduddin M. Prostate specific antigen is raised in polycystic ovary syndrome. Endocrinol Metab Int J. 2018;6(4):297\u2013300. https:\/\/doi.org\/10.15406\/emij.2018.06.00192.","journal-title":"Endocrinol Metab Int J."},{"issue":"04","key":"2187_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1055\/a-0863-5779","volume":"51","author":"A Maleki-Hajiagha","year":"2019","unstructured":"Maleki-Hajiagha A, Razavi M, Rezaeinejad M, Sepidarkish M, Mehri A, Vesali S, et al. Serum prostate-specific antigen level in women with polycystic ovary syndrome: a systematic review and meta-analysis. Horm Metab Res. 2019;51(04):230\u201342. https:\/\/doi.org\/10.1055\/a-0863-5779.","journal-title":"Horm Metab Res"},{"key":"2187_CR23","doi-asserted-by":"crossref","unstructured":"G\u00fcng\u00f6r O, Erden G, Bal C, U\u011fuz N, Sezer S, \u00d6zdemir \u015e, et al. The comparison of free androgen index and serum free testosterone levels in women with hirsutism or polycystic ovary syndrome. J Clin Exp Invest. 2011;2(2). www.clinexpinvest.org.","DOI":"10.5799\/ahinjs.01.2011.02.0230"},{"key":"2187_CR24","doi-asserted-by":"publisher","DOI":"10.4274\/jarem.galenos.2021.22932","author":"E Sa\u011fsak","year":"2021","unstructured":"Sa\u011fsak E, Keskin M, \u00c7etinkaya S, Erdeve \u015eS, Aycan Z. The diagnostic value of free androgen index in obese adolescent females with idiopathic hirsutism and polycystic ovary syndrome. J Acad Res Med. 2021. https:\/\/doi.org\/10.4274\/jarem.galenos.2021.22932.","journal-title":"J Acad Res Med"},{"key":"2187_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cca.2019.09.010","volume":"499","author":"J-l Zhu","year":"2019","unstructured":"Zhu J-l, Chen Z, Feng W-j, Long S-l, Mo Z-C. Sex hormone-binding globulin and polycystic ovary syndrome. Clin Chim Acta. 2019;499:142\u20138. https:\/\/doi.org\/10.1016\/j.cca.2019.09.010.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2187_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-024-01789-w","volume":"24","author":"H Zhang","year":"2024","unstructured":"Zhang H, Qiu W, Zhou P, Shi L, Chen Z, Yang Y, et al. Obesity is associated with SHBG levels rather than blood lipid profiles in PCOS patients with insulin resistance. BMC Endocr Disord. 2024;24(1):254. https:\/\/doi.org\/10.1186\/s12902-024-01789-w.","journal-title":"BMC Endocr Disord"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02187-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-026-02187-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02187-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:45:30Z","timestamp":1789411530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-026-02187-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":26,"alternative-id":["2187"],"URL":"https:\/\/doi.org\/10.1007\/s43032-026-02187-4","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki. Ethical approval was granted by the institutional ethics committee (approval date: April 7, 2022; decision no: 6), and written informed consent was obtained from all participants prior to enrollment.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript does not include any identifiable individual data, images, or personal details; therefore, consent for publication is not required.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report there are no competing interests to declare.","order":3,"name":"Ethics","label":"Disclosure of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used ChatGPT (OpenAI, San Francisco, CA, USA) solely for improving grammar and language clarity. After using this tool, the authors carefully reviewed and edited the content, and take full responsibility for the final version of the manuscript.","order":4,"name":"Ethics","label":"Declaration of Generative AI and AI-assisted Technologies in the Manuscript Preparation Process","group":{"name":"EthicsHeading","label":"Declarations"}}]}}